GDUFA Research Outcomes
Topical Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the topical route, including topical dermatological products.
-
Microstructural Characterization and In Vitro Permeation Testing of Topical Products
Murthy, Narasimha
-
Advanced Characterization Approaches for Topical Formulations
Murthy, Narasimha
-
Characterizing the Critical Quality Attributes and In Vitro Bioavailability of Acyclovir and Metronidazole Topical Products
Murthy, Narasimha
-
Beyond Q1/Q2-Comparing the Arrangement of Matter (Q3) and Performance
Murthy, Narasimha
-
Topical Semisolid Drug Product Critical Quality Attributes (Q3 Characterization) with Relevance to Topical Bioequivalence
Murthy, Narasimha
-
Characterizing Failure Modes And Critical Quality (Q3) Attributes Of Semi-Solid Topical Drug Products
Murthy, Narasimha
-
Evaluating Quality (Q3) Attributes And Potential Failure Modes For Topical Semisolid Drug Products
Murthy, Narasimha
-
“No Difference” Standard vs. Q1/Q2 Sameness for Topical Drug Products
Kelchen, Megan
-
An FDA Perspective on the Comparative Analyses of Critical Material, Quality, and Design Attributes for Topical, Transdermal, Rectal, and Vaginal Drug-Device Combination Products
Kelchen, Megan
-
Locally Acting Drug Update
Luke,Markham